Abstract
We present the Young Supernova Experiment Data Release 1 (YSE DR1), comprised of processed multicolor PanSTARRS1
griz
and Zwicky Transient Facility (ZTF)
gr
photometry of 1975 transients ...with host–galaxy associations, redshifts, spectroscopic and/or photometric classifications, and additional data products from 2019 November 24 to 2021 December 20. YSE DR1 spans discoveries and observations from young and fast-rising supernovae (SNe) to transients that persist for over a year, with a redshift distribution reaching
z
≈ 0.5. We present relative SN rates from YSE’s magnitude- and volume-limited surveys, which are consistent with previously published values within estimated uncertainties for untargeted surveys. We combine YSE and ZTF data, and create multisurvey SN simulations to train the ParSNIP and SuperRAENN photometric classification algorithms; when validating our ParSNIP classifier on 472 spectroscopically classified YSE DR1 SNe, we achieve 82% accuracy across three SN classes (SNe Ia, II, Ib/Ic) and 90% accuracy across two SN classes (SNe Ia, core-collapse SNe). Our classifier performs particularly well on SNe Ia, with high (>90%) individual completeness and purity, which will help build an anchor photometric SNe Ia sample for cosmology. We then use our photometric classifier to characterize our photometric sample of 1483 SNe, labeling 1048 (∼71%) SNe Ia, 339 (∼23%) SNe II, and 96 (∼6%) SNe Ib/Ic. YSE DR1 provides a training ground for building discovery, anomaly detection, and classification algorithms, performing cosmological analyses, understanding the nature of red and rare transients, exploring tidal disruption events and nuclear variability, and preparing for the forthcoming Vera C. Rubin Observatory Legacy Survey of Space and Time.
OBJECTIVETo determine the incidence, cost, and outcome of severe sepsis in the United States.
DESIGNObservational cohort study.
SETTINGAll nonfederal hospitals (n = 847) in seven U.S. states.
...PATIENTSAll patients (n = 192,980) meeting criteria for severe sepsis based on the International Classification of Diseases, Ninth Revision, Clinical Modification.
INTERVENTIONSNone.
MEASUREMENTS AND MAIN RESULTS We linked all 1995 state hospital discharge records (n = 6,621,559) from seven large states with population and hospital data from the U.S. Census, the Centers for Disease Control, the Health Care Financing Administration, and the American Hospital Association. We defined severe sepsis as documented infection and acute organ dysfunction using criteria based on the International Classification of Diseases, Ninth Revision, Clinical Modification. We validated these criteria against prospective clinical and physiologic criteria in a subset of five hospitals. We generated national age- and gender-adjusted estimates of incidence, cost, and outcome. We identified 192,980 cases, yielding national estimates of 751,000 cases (3.0 cases per 1,000 population and 2.26 cases per 100 hospital discharges), of whom 383,000 (51.1%) received intensive care and an additional 130,000 (17.3%) were ventilated in an intermediate care unit or cared for in a coronary care unit. Incidence increased >100-fold with age (0.2/1,000 in children to 26.2/1,000 in those >85 yrs old). Mortality was 28.6%, or 215,000 deaths nationally, and also increased with age, from 10% in children to 38.4% in those >85 yrs old. Women had lower age-specific incidence and mortality, but the difference in mortality was explained by differences in underlying disease and the site of infection. The average costs per case were $22,100, with annual total costs of $16.7 billion nationally. Costs were higher in infants, nonsurvivors, intensive care unit patients, surgical patients, and patients with more organ failure. The incidence was projected to increase by 1.5% per annum.
CONCLUSIONSSevere sepsis is a common, expensive, and frequently fatal condition, with as many deaths annually as those from acute myocardial infarction. It is especially common in the elderly and is likely to increase substantially as the U.S. population ages.
Antagonistic coevolution between hosts and parasites is probably ubiquitous. However, very little is known of the genetic changes associated with parasite infectivity evolution during adaptation to a ...coevolving host. We followed the phenotypic and genetic changes in a lytic virus population (bacteriophage; phage Φ2) that coevolved with its bacterial host, Pseudomonas fluorescens SBW25. First, we show the rapid evolution of numerous unique phage infectivity phenotypes, and that both phage host range and bacterial resistance to individual phage increased over coevolutionary time. Second, each of the distinct phage phenotypes in our study had a unique genotype, and molecular evolution did not act uniformly across the phage genome during coevolution. In particular, we detected numerous substitutions on the tail fibre gene, which is involved in the first step of the host–parasite interaction: host adsorption. None of the observed mutations could be directly linked with infection against a particular host, suggesting that the phenotypic effects of infectivity mutations are probably epistatic. However, phage genotypes with the broadest host ranges had the largest number of nonsynonymous amino acid changes on genes implicated in infectivity evolution. An understanding of the molecular genetics of phage infectivity has helped to explain the complex phenotypic coevolutionary dynamics in this system.
The question of whether health care inequities occur before patients with end‐stage liver disease (ESLD) are waitlisted for transplantation has not previously been assessed. To determine the impact ...of gender, race and insurance on access to transplantation, we linked Pennsylvania sources of data regarding adult patients discharged from nongovernmental hospitals from 1994 to 2001. We followed the patients through 2003 and linked information to records from five centers responsible for 95% of liver transplants in Pennsylvania during this period. Using multinomial logistic regressions, we estimated probabilities that patients would undergo transplant evaluation, transplant waitlisting and transplantation itself. Of the 144 507 patients in the study, 4361 (3.0%) underwent transplant evaluation. Of those evaluated, 3071 (70.4%) were waitlisted. Of those waitlisted, 1537 (50.0%) received a transplant. Overall, 57 020 (39.5%) died during the study period. Patients were less likely to undergo evaluation, waitlisting and transplantation if they were women, black and lacked commercial insurance (p < 0.001 each). Differences were more pronounced for early stages (evaluation and listing) than for the transplantation stage (in which national oversight and review occur). For early management and treatment decisions of patients with ESLD to be better understood, more comprehensive data concerning referral and listing practices are needed.
Linking several secondary data sources, the investigators identified a cohort of liver “transplant‐potential” patients in Pennsylvania and examined the role of sex, race, and insurance status on access to services at early stages of the transplantation process (referral/evaluation, listing).
We present a study of the molecular gas properties in a sample of 98 H i – flux selected spiral galaxies within ∼25 Mpc, using the CO J = 3 − 2 line observed with the James Clerk Maxwell Telescope. ...We use the technique of survival analysis to incorporate galaxies with CO upper limits into our results. Comparing the group and Virgo samples, we find a larger mean H2 mass in the Virgo galaxies, despite their lower mean H i mass. This leads to a significantly higher H2 to H i ratio for Virgo galaxies. Combining our data with complementary Hα star formation rate measurements, Virgo galaxies have longer molecular gas depletion times compared to group galaxies, due to their higher H2 masses and lower star formation rates. We suggest that the longer depletion times may be a result of heating processes in the cluster environment or differences in the turbulent pressure. From the full sample, we find that the molecular gas depletion time has a positive correlation with the stellar mass, indicative of differences in the star formation process between low- and high-mass galaxies, and a negative correlation between the molecular gas depletion time and the specific star formation rate.
Abstract
We present an analysis of the radial profiles of a sample of 43 H i-flux selected spiral galaxies from the Nearby Galaxies Legacy Survey (NGLS) with resolved James Clerk Maxwell Telescope ...(JCMT) CO J = 3 − 2 and/or Very Large Array (VLA) H i maps. Comparing the Virgo and non-Virgo populations, we confirm that the H i discs are truncated in the Virgo sample, even for these relatively H i-rich galaxies. On the other hand, the H2 distribution is enhanced for the Virgo galaxies near their centres, resulting in higher H2 to H i ratios and steeper H2 and total gas radial profiles. This is likely due to the effects of moderate ram pressure stripping in the cluster environment, which would preferentially remove low-density gas in the outskirts while enhancing higher density gas near the centre. Combined with Hα star formation rate data, we find that the star formation efficiency (SFR/H2) is relatively constant with radius for both samples, but the Virgo galaxies have an ∼40 per cent lower star formation efficiency than the non-Virgo galaxies.
Differentiating acute bacterial infection from other causes of lower respiratory tract illness is challenging. In this trial, procalcitonin was investigated as a point-of-care test to aid in ...determining whether antibiotics were needed in the treatment of these illnesses.
Increased levels of atmospheric CO sub(2) are anticipated to cause decreased seawater pH. Despite the fact that calcified marine invertebrates are particularly susceptible to acidification, barnacles ...have received little attention. We examined larval condition, cyprid size, cyprid attachment and metamorphosis, juvenile to adult growth, shell calcium carbonate content, and shell resistance to dislodgement and penetration in the barnacle Amphibalanus amphitrite reared from nauplii in either ambient pH 8.2 seawater or under CO sub(2)-driven acidification of seawater down to a pH of 7.4. There were no effects of reduced pH on larval condition, cyprid size, cyprid attachment and metamorphosis, juvenile to adult growth, or egg production. Nonetheless, barnacles exposed to pH 7.4 seawater displayed a trend of larger basal shell diameters during growth, suggestive of compensatory calcification. Furthermore, greater force was required to cause shell breakage of adults raised at pH 7.4, indicating that the lower, active growth regions of the wall shells had become more heavily calcified. Ash contents (predominately calcium carbonate) of basal shell plates confirmed that increased calcification had occurred in shells of individuals reared at pH 7.4. Despite enhanced calcification, penetrometry revealed that the central shell wall plates required significantly less force to penetrate than those of individuals raised at pH 8.2. Thus, dissolution rapidly weakens wall shells as they grow. The ramifications of our observations at the population level are important, as barnacles with weakened wall shells are more vulnerable to predators.
Although diabetes mellitus is implicated in susceptibility to infection, the association of diabetes with the subsequent course and outcome is unclear.
A retrospective analysis of two multicentre ...cohorts was carried out. The effect of pre-existing diabetes on the host immune response, acute organ function and mortality in patients hospitalised with community-acquired pneumonia (CAP) in the GenIMS study (n=1895) and on mortality following either CAP or non-infectious hospitalisations in the population-based cohort study, Health ABC (n=1639) was determined. Measurements included the mortality rate within the first year, risk of organ dysfunction, and immune responses, including circulating inflammatory (tumour necrosis factor, interleukin 6, interleukin 10), coagulation (Factor IX, thrombin-antithrombin complexes, antithrombin), fibrinolysis (plasminogen-activator inhibitor-1 and D-dimer) and cell surface markers (CD120a, CD120b, human leucocyte antigen (HLA)-DR, Toll-like receptor-2 and Toll-like receptor-4).
In GenIMS, diabetes increased the mortality rate within the first year after CAP (unadjusted HR 1.41, 95% CI 1.12 to 1.76, p=0.002), even after adjusting for pre-existing cardiovascular and renal disease (adjusted HR 1.3, 95% CI 1.03 to 1.65, p=0.02). In Health ABC, diabetes increased the mortality rate within the first year following CAP hospitalisation, but not after hospitalisation for non-infectious illnesses (significant interaction for diabetes and reason for hospitalisation (p=0.04); HR for diabetes on mortality over the first year after CAP 1.87, 95% CI 0.76 to 4.6, p=0.16, and after non-infectious hospitalisation 1.16, 95% CI 0.8 to 1.6, p=0.37). In GenIMS, immediate immune response was similar, as evidenced by similar circulating immune marker levels, in the emergency department and during the first week. Those with diabetes had a higher risk of acute kidney injury during hospitalisation (39.3% vs 31.7%, p=0.005) and they were more likely to die due to cardiovascular and kidney disease (34.4% vs 26.8% and 10.4% vs 4.5%, p=0.03).
Pre-existing diabetes was associated with a higher risk of death following CAP. The mechanism is not due to an altered immune response, at least as measured by a broad panel of circulating and cell surface markers, but may be due to worsening of pre-existing cardiovascular and kidney disease.
Point-of-care sensors that enable the fast collection of information relevant to a patient's health state can facilitate improved health access, reduce healthcare costs and improve the quality of ...healthcare delivery. In the diagnosis of sepsis - defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection, and the leading cause of in-patient death and of hospital readmission in the United States - predicting which infections will lead to life-threatening organ dysfunction and developing specific anti-sepsis treatments remain challenging because of the significant heterogeneity of the host response. Yet the use of point-of-care devices could reduce the time from the onset of a patient's infection to the administration of appropriate therapeutics. In this Perspective, we describe the current state of point-of-care sensors for the diagnosis and monitoring of sepsis, and outline opportunities in the use of these devices to dramatically improve patient care.
PDF
